Annual Report And Accounts

Overview

The report describes a difficult 2025 marked by a strategic review and a reset toward a hybrid R&D and commercial model. Group revenue fell to £1.7 million, while Eroxon® Intense and WSD4000 advanced through development. Its sustainability review focuses on four SDGs and links them to sexual health, equality, employee development and R&D.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2025
Period: Ends 31 December 2025
Publication date: 2 June 2026
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services